LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer. Shen S, Wu Y, Shao Z, Li Y, et al. Cancer Sci 2025 Mar 17. doi: 10.1111/cas.70049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shen S, Wu Y, Shao Z, Li Y, et al. LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer. Cancer Sci 2025 Mar 17. doi: 10.1111/cas.70049.
PMID: 40095278